BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20046091)

  • 1. A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone).
    Baek EJ; Lee S; Kim S; Choi HK; Kim HO
    Korean J Lab Med; 2009 Dec; 29(6):578-84. PubMed ID: 20046091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoperazone/sulbactam-induced hemolytic anemia.
    Sun XM; Liu LH; Wu Q; Wang HG
    J Postgrad Med; 2023; 69(1):46-49. PubMed ID: 34528516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing spectrum of drug-induced immune hemolytic anemia.
    Arndt PA; Garratty G
    Semin Hematol; 2005 Jul; 42(3):137-44. PubMed ID: 16041663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
    Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
    Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
    Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
    Front Immunol; 2021; 12():698541. PubMed ID: 35003054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy.
    Wu Y; Wu Y; Ji Y; Liang J; He Z; Liu Y; Tang L; Guo G
    Front Med (Lausanne); 2021; 8():697192. PubMed ID: 34485334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune hemolytic anemia caused by drugs.
    Garratty G
    Expert Opin Drug Saf; 2012 Jul; 11(4):635-42. PubMed ID: 22502777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam.
    Zhou L; Bao J; Ma J
    Front Pharmacol; 2019; 10():1342. PubMed ID: 31798450
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma.
    Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA
    Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fatal case of suspected anaphylaxis with cefoperazone and sulbactam: LC-MS analysis.
    Tsujikawa K; Kuwayama K; Miyaguchi H; Kanamori T; Iwata Y; Inoue H; Kishi T
    J Forensic Sci; 2008 Jan; 53(1):226-31. PubMed ID: 18279263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody.
    Gniadek TJ; Arndt PA; Leger RM; Zydowicz D; Cheng EY; Zantek ND
    Transfusion; 2018 Jan; 58(1):181-188. PubMed ID: 28990203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked reduction in haemoglobin levels secondary to ceftizoxime-induced immune haemolytic anaemia in diabetic patients.
    Wu S; Jing L; Feng Y; Chen L
    J Clin Pharm Ther; 2020 Aug; 45(4):812-814. PubMed ID: 32319116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced immune hemolytic anemia.
    Garratty G
    Hematology Am Soc Hematol Educ Program; 2009; ():73-9. PubMed ID: 20008184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first case of drug-induced immune hemolytic anemia due to hydrocortisone.
    Martinengo M; Ardenghi DF; Tripodi G; Reali G
    Transfusion; 2008 Sep; 48(9):1925-9. PubMed ID: 18565121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological studies of piperacillin antibodies.
    Leger RM; Arndt PA; Garratty G
    Transfusion; 2008 Nov; 48(11):2429-34. PubMed ID: 18657075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells.
    Garratty G; Arndt PA
    Br J Haematol; 1998 Mar; 100(4):777-83. PubMed ID: 9531349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced immune hemolytic anemia: the last 30 years of changes.
    Arndt PA
    Immunohematology; 2014; 30(2):44-54. PubMed ID: 25247622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftizoxime-induced hemolysis due to immune complexes: case report and determination of the epitope responsible for immune complex-mediated hemolysis.
    Endoh T; Yagihashi A; Sasaki M; Watanabe N
    Transfusion; 1999 Mar; 39(3):306-9. PubMed ID: 10204595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftizoxime-induced hemolysis secondary to combined drug adsorption and immune-complex mechanisms.
    Calhoun BW; Junsanto T; Donoghue MT; Naureckas E; Baron JM; Baron BW
    Transfusion; 2001 Jul; 41(7):893-7. PubMed ID: 11452157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.